Author: Ken Dropiewski

Heart and Vascular Patient Care Expands to Serve Western Colorado and Eastern Utah

GRAND JUNCTION, Colo., May 22, 2019 /PRNewswire/ — SCL Health St. Mary’s Medical Center is pleased to announce the opening of a new $48.5 million, 46,000 square foot Heart & Vascular Institute in Grand Junction, Colorado. The institute brings advanced care and minimally invasive procedures to western Colorado and eastern Utah, such as TAVR/TAVI heart valve implants, other interventional […]

Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy Data for the Neovasc Reducer™ in a Peer Reviewed Article in the International Journal of Cardiology

VANCOUVER, May 22, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that the International Journal of Cardiology has published a […]

Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation

MARLBOROUGH, Mass., May 22, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has initiated the OPTION trial to compare safety and effectiveness of the next-generation WATCHMAN FLX™ left atrial appendage closure (LAAC) platform to first-line oral anticoagulants (OAC) – including direct oral anticoagulants (DOAC) and warfarin – for stroke risk reduction in patients with […]

Results Announced from Two Renal Denervation Studies at EuroPCR Show Positive Outcomes in High-Risk Hypertensive Patients

DUBLIN and PARIS – May 22, 2019 – Investigators today unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical trial. The data indicate that renal denervation (RDN) with the Medtronic Symplicity(TM) renal denervation system was associated with reduced occurrence of subclinical atrial fibrillation (AF) in a small subset of high-risk […]

Edwards Announces Milestones For Transcatheter Mitral Program

PARIS, May 22, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regulatory milestones for its Edwards PASCAL transcatheter valve repair system. Today at the EuroPCR annual course in Paris, new 6-month data from the CLASP study of […]

Pi-Cardia First-in-Human Study Shows Significant Improvement in Aortic Valve Function Following Treatment With its Novel Non-Implant Based Leaflex™ Catheter

PARIS, May 22, 2019 /PRNewswire/ — Pi-Cardia Ltd. announced today that it successfully completed its First-in-Human study demonstrating substantial improvement in valve function following treatment with its Leaflex™ Performer catheter. The Leaflex™ Performer is a transfemoral catheter that uses two unique mechanical structures for scoring valve calcification at multiple locations, restoring leaflets […]

WomenHeart Celebrates 20 Years of Service and Honors Women’s Heart Health Advocates at Annual Wenger Awards

WASHINGTON–(BUSINESS WIRE)–WomenHeart: The National Coalition for Women with Heart Disease recognized contributions to women’s cardiovascular health at its 2019 Wenger Awards. The organization also celebrated 20 years of providing support, education and advocacy for the 48 million women living with or at risk of heart disease. “It’s been an incredible […]

Hemovent Receives CE Marking for MOBYBOX™ ECLS System

AACHEN, Germany–(BUSINESS WIRE)–Hemovent GmbH announced today that it has received CE Marking for its MOBYBOX™ ECLS System, allowing the company to market its innovative product throughout the European Union. MOBYBOX is a miniaturized heart/lung machine that uses Hemovent’s proprietary Bionique Flow Technologies as its platform. As the world’s first self-contained and fully integrated […]